Tizanidine Hydrochloride

Product NDC
59746-671
11-digit product format
597460671
Labeler code
59746
Product ID
59746-671_b384b1a9-6301-4d3f-a6f1-4deb5f58e6e6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tizanidine Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Jubilant Cadista Pharmaceuticals Inc.
Application
ANDA209605
Marketing category
ANDA
Marketing start
2017-08-04
Marketing end
0000-00-00
Substance
TIZANIDINE
Active strength
4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59746-671TIZANIDINE HYDROCHLORIDE (TIZANIDINE HYDROCHLORIDE) CAPSULE [JUBILANT CADISTA PHARMACEUTICALS INC.]3Legacy NDC20170811_e803d28e-0610-a52c-3295-dd2d148531aa.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
59746-671-0159746067101100 CAPSULE in 1 BOTTLE (59746-671-01) 100 capsule2017-08-040000-00-00NoNoCurrent
59746-671-10597460671101000 CAPSULE in 1 BOTTLE (59746-671-10) 1000 capsule2017-08-040000-00-00NoNoCurrent
59746-671-305974606713030 CAPSULE in 1 BOTTLE (59746-671-30) 30 capsule2017-08-040000-00-00NoNoCurrent
59746-671-3459746067134150 CAPSULE in 1 BOTTLE (59746-671-34) 150 capsule2017-08-040000-00-00NoNoCurrent